Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial

Abstract Background Perioperative chemotherapy combined with D2 radical gastrectomy has been proven to be the standard treatment for local advanced gastric cancer. However, tumor regression grading (TRG) is the only neoadjuvant chemotherapy (NACT) response evaluation criterion recommended by the NCC...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuejun Gan, Yongning Jia, Fei Shan, Xiangji Ying, Shuangxi Li, Yan Zhang, Fei Pang, Ziyu Li
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-13372-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850252021148418048
author Xuejun Gan
Yongning Jia
Fei Shan
Xiangji Ying
Shuangxi Li
Yan Zhang
Fei Pang
Ziyu Li
author_facet Xuejun Gan
Yongning Jia
Fei Shan
Xiangji Ying
Shuangxi Li
Yan Zhang
Fei Pang
Ziyu Li
author_sort Xuejun Gan
collection DOAJ
description Abstract Background Perioperative chemotherapy combined with D2 radical gastrectomy has been proven to be the standard treatment for local advanced gastric cancer. However, tumor regression grading (TRG) is the only neoadjuvant chemotherapy (NACT) response evaluation criterion recommended by the NCCN guideline for gastric cancer (GC). Given TRG’s limitations, we aim to explore a better comprehensive response evaluation method in this study. Methods Clinical information of 96 GC patients who received NACT was collected prospectively. Clinicopathological variables predictive of the response to NACT were identified by comparing the pre- and post-NACT examination results. The correlations between the response mode and long-term survival rate were assessed. Results Univariate Cox regression analysis showed that CT-based evaluation of the primary lesion thickness (CT-thickness) and tumor markers (TMs) were significantly associated with prognosis. The comprehensive evaluation method, including CT-thickness, TRG, and TMs, was constructed and proved to have a higher Harrell’s C index. Significant differences in overall survival (OS) and recurrence-free survival (RFS) were observed between responders and non-responders distinguished by the comprehensive evaluation method. Conclusions The combination of CT-thickness, TRG, and TMs could be used to construct a pragmatic NACT efficacy evaluation method with both high sensitivity and specificity, which could facilitate clinical decision-making, NACT-related clinical research conduction, and efficacy predictive biomarker exploration.
format Article
id doaj-art-e2c3a0bab4874957b528f3f5772a2dc2
institution OA Journals
issn 1471-2407
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-e2c3a0bab4874957b528f3f5772a2dc22025-08-20T01:57:45ZengBMCBMC Cancer1471-24072025-03-0125111310.1186/s12885-024-13372-6Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trialXuejun Gan0Yongning Jia1Fei Shan2Xiangji Ying3Shuangxi Li4Yan Zhang5Fei Pang6Ziyu Li7Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & Institute State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, gastrointestinal surgery of department, Peking University Cancer Hospital & Institute State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, gastrointestinal surgery of department, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & InstituteAbstract Background Perioperative chemotherapy combined with D2 radical gastrectomy has been proven to be the standard treatment for local advanced gastric cancer. However, tumor regression grading (TRG) is the only neoadjuvant chemotherapy (NACT) response evaluation criterion recommended by the NCCN guideline for gastric cancer (GC). Given TRG’s limitations, we aim to explore a better comprehensive response evaluation method in this study. Methods Clinical information of 96 GC patients who received NACT was collected prospectively. Clinicopathological variables predictive of the response to NACT were identified by comparing the pre- and post-NACT examination results. The correlations between the response mode and long-term survival rate were assessed. Results Univariate Cox regression analysis showed that CT-based evaluation of the primary lesion thickness (CT-thickness) and tumor markers (TMs) were significantly associated with prognosis. The comprehensive evaluation method, including CT-thickness, TRG, and TMs, was constructed and proved to have a higher Harrell’s C index. Significant differences in overall survival (OS) and recurrence-free survival (RFS) were observed between responders and non-responders distinguished by the comprehensive evaluation method. Conclusions The combination of CT-thickness, TRG, and TMs could be used to construct a pragmatic NACT efficacy evaluation method with both high sensitivity and specificity, which could facilitate clinical decision-making, NACT-related clinical research conduction, and efficacy predictive biomarker exploration.https://doi.org/10.1186/s12885-024-13372-6Gastric cancerNeoadjuvant chemotherapy (NACT)Tumor regression grading (TRG)Tumor marker (TM)Response evaluation
spellingShingle Xuejun Gan
Yongning Jia
Fei Shan
Xiangji Ying
Shuangxi Li
Yan Zhang
Fei Pang
Ziyu Li
Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial
BMC Cancer
Gastric cancer
Neoadjuvant chemotherapy (NACT)
Tumor regression grading (TRG)
Tumor marker (TM)
Response evaluation
title Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial
title_full Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial
title_fullStr Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial
title_full_unstemmed Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial
title_short Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial
title_sort comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer a post hoc analysis of a single center randomized controlled trial
topic Gastric cancer
Neoadjuvant chemotherapy (NACT)
Tumor regression grading (TRG)
Tumor marker (TM)
Response evaluation
url https://doi.org/10.1186/s12885-024-13372-6
work_keys_str_mv AT xuejungan comprehensiveevaluationoftumorresponsebetterevaluatestheefficacyofneoadjuvantchemotherapyandpredictstheprognosisingastriccanceraposthocanalysisofasinglecenterrandomizedcontrolledtrial
AT yongningjia comprehensiveevaluationoftumorresponsebetterevaluatestheefficacyofneoadjuvantchemotherapyandpredictstheprognosisingastriccanceraposthocanalysisofasinglecenterrandomizedcontrolledtrial
AT feishan comprehensiveevaluationoftumorresponsebetterevaluatestheefficacyofneoadjuvantchemotherapyandpredictstheprognosisingastriccanceraposthocanalysisofasinglecenterrandomizedcontrolledtrial
AT xiangjiying comprehensiveevaluationoftumorresponsebetterevaluatestheefficacyofneoadjuvantchemotherapyandpredictstheprognosisingastriccanceraposthocanalysisofasinglecenterrandomizedcontrolledtrial
AT shuangxili comprehensiveevaluationoftumorresponsebetterevaluatestheefficacyofneoadjuvantchemotherapyandpredictstheprognosisingastriccanceraposthocanalysisofasinglecenterrandomizedcontrolledtrial
AT yanzhang comprehensiveevaluationoftumorresponsebetterevaluatestheefficacyofneoadjuvantchemotherapyandpredictstheprognosisingastriccanceraposthocanalysisofasinglecenterrandomizedcontrolledtrial
AT feipang comprehensiveevaluationoftumorresponsebetterevaluatestheefficacyofneoadjuvantchemotherapyandpredictstheprognosisingastriccanceraposthocanalysisofasinglecenterrandomizedcontrolledtrial
AT ziyuli comprehensiveevaluationoftumorresponsebetterevaluatestheefficacyofneoadjuvantchemotherapyandpredictstheprognosisingastriccanceraposthocanalysisofasinglecenterrandomizedcontrolledtrial